3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
28
Prostatic Neoplasms
14
Neoplasm Metastasis
12
Osteoporosis
8
Multiple Myeloma
8
Pain
7
Lung Neoplasms
4
Fractures, Bone
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasms, Plasma Cell
3
Humoral Hypercalcemia Of Malignancy
3
Bone Neoplasms
3
Bone Diseases, Metabolic
3
Spinal Cord Compression
2
Neoplasms
2
Lymphoma
2
Hematologic Neoplasms
2
Triple Negative Breast Neoplasms
1
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Paraproteinemias
1
Osteosarcoma
1
Neoplastic Processes
1
Lymphoma, Non-Hodgkin
1
Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors
1
Hematologic Diseases
1
Giant Cell Tumor of Bone
1
Disease Progression
1
Interventions
Doxorubicin
25
Ifosfamide
22
Radiotherapy
17
Etoposide
11
Vincristine
10
Cyclophosphamide
10
Filgrastim
8
Dactinomycin
8
Trabectedin
7
Chemotherapy, Adjuvant
5
pazopanib
4
Cisplatin
4
Topotecan
3
Radiation
3
Neoadjuvant Therapy
3
Irinotecan
3
Granulocyte Colony-Stimulating Factor
3
Dacarbazine
3
sargramostim
2
etoposide phosphate
2
eribulin
2
Observation
2
Methotrexate
2
Mesna
2
Imatinib Mesylate
2
Gemcitabine
2
Epirubicin
2
Docetaxel
2
Dexrazoxane
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Sarcoma
×
Zoledronic Acid
×
Clear all
NCT00470223
2025-06-08
OS2006
UNICANCER
Phase 3
Active not recruiting
318 enrolled